An estimated 200 million children under 5 years of age (more than 30% of the world’s children) in Low and Middle Income Countries fail to reach their cognitive and developmental potential due to exposure to potentially debilitating conditions such as infectious diseases, malnutrition and poverty. The neurodevelopmental research group in Kilifi is a multidisciplinary team that aims at understanding the neurocognitive and neuropsychiatric burden associated with various childhood diseases (e.g. HIV, malaria, and Epilepsy) in the African context. Moreover, we also aim at developing culturally appropriate and contextually relevant strategies for identifying, monitoring and rehabilitating children who are at-risk of experiencing developmental delays and impairments. We are currently working on estimating prevalence and risk factors for neurodevelopmental disorders especially Autism Spectrum Disorders. 
We use multimethod approaches to assess child development, including traditional paper and pencil neurocognitive testing, qualitative approaches and neurophysiological tests- ERPs and EEGs. 
For further information: https://neurodev.kemri-wellcome.org/